+398.1%
RMBS vs THC
+1,458.3%
-1,060.1%
-61.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -12.9% | -0.2% | -12.8% | -12.9% |
| 7D | -19.3% | -8.0% | -11.3% | -18.2% |
| 30D | -28.5% | -2.2% | -26.3% | -28.4% |
| 3M | -28.0% | -3.5% | -24.5% | -27.8% |
| 6M | -50.3% | +40.4% | -90.8% | -54.2% |
| YTD | -27.8% | +32.4% | -60.2% | -33.3% |
| 1Y | -24.0% | +41.0% | -65.0% | -30.8% |
| 3Y | -4.7% | +305.2% | -309.9% | -30.2% |
| 5Y | +143.7% | +239.8% | -96.2% | +78.8% |
| All | +398.1% | +1,458.3% | -1,060.1% | +167.9% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling